You are mistaken should you recall that this was a
Post# of 36536
(Total Views: 324)
Posted On: 08/24/2022 7:36:26 AM
You are mistaken should you recall that this was all JM.
The specifics about the financing deal that was about ready to be signed and was supposed to be used to BIG TIME roll out Excellagen into the US market and beyond, was Anthony Dolisi during the May 21 conference call.
That is what I meant to point out in my previous post. Even if the captain has abandoned the GNBT ship, which cannot be emphasized enough what an EMBARRASSMENT that should be for himself. There should still be the captain of that "barge" (in order to stay in that nautical metaphor) called Olaregen, who should take care of his own business, and get his product launch handled, as he laid out plans for to us during that CC. And if only half of his "forward looking statements" made during that CC have come true until now, Olaregen should be generating double digit million dollar revenues in Excellagen sales by now.
So it is not just about the - what you kept calling it - "smoke and mirrors" of a dilusional con artist by the name JM, but hopefully a much more reliable Olaregen CEO named Anthony Dolisi. Even if his mother corporation is in trouble, he should still continue to do his own job, right?
The specifics about the financing deal that was about ready to be signed and was supposed to be used to BIG TIME roll out Excellagen into the US market and beyond, was Anthony Dolisi during the May 21 conference call.
That is what I meant to point out in my previous post. Even if the captain has abandoned the GNBT ship, which cannot be emphasized enough what an EMBARRASSMENT that should be for himself. There should still be the captain of that "barge" (in order to stay in that nautical metaphor) called Olaregen, who should take care of his own business, and get his product launch handled, as he laid out plans for to us during that CC. And if only half of his "forward looking statements" made during that CC have come true until now, Olaregen should be generating double digit million dollar revenues in Excellagen sales by now.
So it is not just about the - what you kept calling it - "smoke and mirrors" of a dilusional con artist by the name JM, but hopefully a much more reliable Olaregen CEO named Anthony Dolisi. Even if his mother corporation is in trouble, he should still continue to do his own job, right?
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼